Shiva Akbari-Birgani

Dr. Shiva Akbari-Birgani

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2019 in Nanomedicine
Verified
Journal Article
Closed access
MMMasoud Mohseni-Dargah
Masoud Mohseni-Dargah
SAShiva Akbari-Birgani
Shiva Akbari-Birgani
ZMZahra Madadi
Zahra Madadi
FSFatemeh Saghatchi
Fatemeh Saghatchi
BKBabak Kaboudin
Babak Kaboudin
Aim: To induce a safe death to MCF-7 human breast cancer cell line through gene therapy based on iC9 suicide gene. Materials & methods: To induce apoptosis to MCF-7 cell line, iC9 gene was transfected using pyridine-functionalized multi-walled carbon nanotubes. Then, to enhance chemotherapy, iC9 suicide gene therapy was performed alongside. Results: The results show that the MCF-7 cells were efficiently eliminated in a high percentage by this approach. Furthermore, the suicide gene by itself/in combination with the chemotherapeutic drugs managed to pass the cell cycle arrests. Conclusion: We introduced an in vitro treatment approach based on suicide gene therapy and the first step was taken toward the enhancement of chemotherapy, although more investigation is required.

22 February 2020 in Applied Biochemistry and Biotechnology
Verified
Journal Article
Closed access
PDF file
FSFatemeh Saghatchi
Fatemeh Saghatchi
MMMasoud Mohseni-Dargah
Masoud Mohseni-Dargah
SAShiva Akbari-Birgani
Shiva Akbari-Birgani
SSSamaneh Saghatchi
Samaneh Saghatchi
BKBabak Kaboudin
Babak Kaboudin


1 December 2019 in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Verified
Journal Article
Closed access
ZMZahra Madadi
Zahra Madadi
SAShiva Akbari-Birgani
Shiva Akbari-Birgani
PMParviz Davoodi Monfared
Parviz Davoodi Monfared
SMSaeed Mohammadi
Saeed Mohammadi

5 November 2020 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
PDParviz Davoodi‐Monfared
Parviz Davoodi‐Monfared
SAShiva Akbari-Birgani
Shiva Akbari-Birgani
SMSaeed Mohammadi
Saeed Mohammadi
FKFoad Kazemi
Foad Kazemi
NNNasser Nikfarjam
Nasser Nikfarjam
SMSeyed Asadollah Mousavi
Seyed Asadollah Mousavi

15 October 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
RTReza Taghizadeh-Tabarsi
Reza Taghizadeh-Tabarsi
SAShiva Akbari-Birgani
Shiva Akbari-Birgani
MAMehrnaz Amjadi
Mehrnaz Amjadi
SMSoheila Mohammadi
Soheila Mohammadi
NNNasser Nikfarjam
Nasser Nikfarjam
KKKosuke Kusamori
Kosuke Kusamori
Breast cancer is one of the most common cancers in women. One of the best therapeutic methods against breast cancer is gene therapy, while having an appropriate gene carrier is the biggest challenge of gene therapy. Hence, developing carriers with low cytotoxicity and high gene transfection efficiency, and preferentially with the selective function of gene delivery is a critical demand for this method. In the present study, we introduce a novel targeted carrier to deliver the inducible caspase-9 suicide gene (pLVSIN-iC9) into breast cancer cells. The carrier is composed of graphene oxide quantum dots decorated with polyethyleneimine, and S2.2; an aptamer with high affinity to MUC1 (GOQD-PEI/S2.2). Due to the overexpression of MUC1 in breast cancer cells, the designed GOQD-PEI/S2.2/pLVSIN-iC9 can selectively target cancer cells. Moreover, to better mimic solid tumor conditions, and to evaluate the selective effect of the GOQD-PEI/S2.2/pLVSIN-iC9, an organoid model derived from human dermal fibroblasts (HDF) and MCF-7 cells (coculture organoid) was generated and characterized. The results demonstrate that the coculture organoid model adapts the tissue structure of luminal breast cancer, as well. Therefore, the organoids were subjected to treatment with targeted gene therapy using GOQD-PEI/S2.2/pLVSIN-iC9. Our evidence supports the targeted killing effect of iC9 on the breast cancer cells of the organoids and suggests the good potential of the newly introduced carriers in targeted gene delivery.